Central retinal artery occlusion, or CRAO, is a sudden blockage of the main artery supplying blood to the retina, and it is increasingly recognized as a form of stroke that happens in the eye rather than the brain. The blockage starves retinal tissue of oxygen, causing rapid and often devastating vision loss in the affected eye. Because the retina’s nerve cells can begin dying within minutes of lost blood flow, CRAO is a genuine ophthalmic emergency with a narrow window for meaningful intervention.
What Causes the Blockage
The central retinal artery is a small vessel, roughly the diameter of a thick human hair, that enters the eye through the optic nerve and branches across the inner retina. When something plugs that artery, the tissue downstream loses its oxygen supply almost instantly. The most common culprit is an embolus, a fragment of material that breaks free from somewhere else in the body and lodges in the artery. The three main types of emboli found in retinal artery occlusion are cholesterol fragments, calcium deposits, and clots made of platelets and fibrin. These fragments typically originate from plaques in the carotid arteries in the neck or from abnormal heart valves and chambers.1PubMed Central. Retinal arterial occlusion with multiple retinal emboli and carotid artery occlusion disease: haemodynamic changes and pathways of embolism
Because these emboli come from the same atherosclerotic plaques that cause heart attacks and brain strokes, the risk factors for CRAO mirror those of cardiovascular disease broadly: high blood pressure, high cholesterol, diabetes, smoking, and advancing age.2PubMed Central. Treatment options for central retinal artery occlusion Less commonly, CRAO can result from inflammation of the artery wall, as in giant cell arteritis, a condition seen mostly in people over 50. This arteritic form is rarer but critical to identify because it can be treated with steroids and may threaten the other eye if missed. Other uncommon causes include clotting disorders, severe low blood pressure during surgery, and trauma to the orbit.
Who Is Most Affected
CRAO is relatively rare in the general population but becomes sharply more common with age. A nationwide study in Korea found the overall incidence was roughly 1.8 per 100,000 person-years, but among people aged 80 to 84 it climbed to about 10 per 100,000, with men consistently affected more than women across all age groups.3PubMed. Nationwide incidence of clinically diagnosed central retinal artery occlusion in Korea, 2008 to 2011 A long-running study in Olmsted County, Minnesota found the average age at presentation was about 74, with a range of 46 to 90, and roughly 60% of cases occurred in men.4American Journal of Ophthalmology. The Incidence of Central Retinal Artery Occlusion in Olmsted County, Minnesota Younger adults can develop CRAO, but when they do, the cause is more often a clotting disorder, cardiac abnormality, or arterial dissection rather than typical atherosclerosis.
What Sudden Vision Loss Feels Like
CRAO typically announces itself as a painless, abrupt loss of vision in one eye. Most people describe it as a curtain falling or a sudden dimming that happens over seconds to minutes, not gradually over days. Because it usually affects only one eye, someone might not even notice immediately if the other eye compensates in everyday tasks. The vision loss tends to be severe: many patients are left with only the ability to perceive hand motions or light in the affected eye.
In some cases, a person experiences brief episodes of vision loss in the same eye in the days or weeks before the permanent event. These transient episodes, sometimes called amaurosis fugax, are caused by temporary blockages that clear on their own. They are a major warning sign. Anyone who experiences even a fleeting blackout of vision in one eye should seek urgent evaluation, because it may signal an embolus source that could produce a complete and permanent occlusion next time.
How Quickly the Retina Is Damaged
One of the most alarming features of CRAO is the speed at which irreversible damage occurs. The retinal ganglion cells, the nerve cells that relay visual information to the brain, are part of the central nervous system. Like brain neurons during a stroke, they are exquisitely sensitive to oxygen deprivation. A detailed analysis of the experimental evidence concluded that significant, irreversible ganglion cell death likely begins after just 12 to 15 minutes of complete blood flow interruption, far shorter than the 90-to-240-minute window traditionally cited in older medical literature.5PubMed Central. Central retinal artery occlusion – rethinking retinal survival time
Animal studies have provided a slightly more hopeful picture for partial recovery: if blood flow is restored within roughly 97 minutes, full reversal of retinal damage may be possible, and partial recovery has been observed when flow returns within about 240 minutes.6Eye. Central retinal artery occlusion: a stroke of the eye The tension between these findings reflects a real gap in the science. The aggressive 12-to-15-minute estimate applies to total, complete occlusion, but in practice many cases involve incomplete blockages where a trickle of blood still gets through, buying some extra time. The practical takeaway is stark either way: every minute counts, and delays of even an hour or two can mean the difference between some preserved vision and none.
How Doctors Diagnose It
An experienced eye doctor can often diagnose CRAO within minutes using a direct ophthalmoscope or slit lamp. The classic appearance is a pale, whitened retina with a distinctive bright red spot at the center of the macula, known as the “cherry-red spot.” The whitening occurs because the swollen, oxygen-starved inner retinal layers become opaque, while the thin fovea at the very center still shows the red color of the underlying choroidal blood supply.
More advanced imaging adds detail and certainty. Fluorescein angiography, where a dye is injected into a vein and photographed as it flows through retinal vessels, can reveal delayed filling of the retinal arteries. In one study, delayed arteriovenous transit time was seen in over half of cases, while a quarter showed normal angiography results, indicating the blockage had already cleared by the time the test was performed.7PubMed Central. Multimodal Imaging of Acute Central Retinal Artery Occlusion Optical coherence tomography, or OCT, which produces cross-sectional images of the retina, typically shows swelling of the inner retinal layers in the acute phase. OCT is fast, noninvasive, and increasingly available in emergency departments, making it a practical tool for confirming the diagnosis quickly. One hospital protocol that placed OCT devices in the emergency department was able to diagnose retinal artery occlusion remotely, with OCT performed on average within about two and a half hours of the patient arriving.8PubMed. Eye stroke protocol in the emergency department
Treatment Options and Their Limitations
Treating CRAO has been one of ophthalmology’s most frustrating challenges. Dozens of approaches have been tried over the past century and a half since the condition was first described in 1859, and most have failed to show clear benefit in controlled studies.9PubMed Central. Update on central retinal artery occlusion That landscape is starting to shift, but the honest assessment is that no treatment has become a reliable standard of care.
Ocular Massage
One of the oldest and simplest interventions is ocular massage, where firm, repeated pressure is applied to the eye through the closed eyelid. The idea is that large swings in pressure inside the eye could physically dislodge the embolus and push it into a smaller branch vessel, opening up blood flow to a larger area of retina. The technique causes the retinal arteries to dilate, and the pressure fluctuations may help break up or shift the clot.10PubMed Central. Ocular massage in central retinal artery occlusion: Monitoring vascular recovery with optical coherence tomography angiography – A case series Ocular massage can be started immediately, even before arriving at a hospital, which is its main advantage. Individual case reports describe dramatic recoveries, but large controlled trials proving it works are lacking.
Anterior Chamber Paracentesis and Carbogen
Another traditional approach involves drawing a tiny amount of fluid from the front chamber of the eye with a needle, which drops the intraocular pressure abruptly, combined with having the patient breathe carbogen, a mixture of carbon dioxide and oxygen designed to dilate blood vessels. However, a controlled study comparing this combination against no treatment found no statistically significant difference in visual outcomes, with adequate statistical power to detect a meaningful difference.11PubMed. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion This result has dampened enthusiasm for the approach, though some clinicians still use it as part of a combination strategy given its low risk.
Intravenous Thrombolysis
The most promising recent development is treating CRAO the same way neurologists treat brain strokes: with clot-dissolving drugs given intravenously. One study compared tenecteplase, a newer thrombolytic, against standard medical management and found that patients who received tenecteplase were roughly six to seven times more likely to have vision better than 20/200 at their first follow-up. The treated group also had significantly better visual acuity at both the first and final follow-ups, and no symptomatic brain or eye hemorrhages occurred within a week of treatment.12PubMed. Visual outcome comparison of intravenous thrombolysis after central retinal artery occlusions These results are encouraging, but the evidence base remains small, and the treatment carries the inherent risks of any blood-thinning therapy.
Intra-arterial thrombolysis, where the clot-dissolving drug is threaded through a catheter directly to the blocked artery, has also been explored. Case reports have demonstrated complete restoration of retinal blood flow on imaging after the procedure.13PubMed Central. Intra-arterial thrombolysis for central retinal artery occlusion: two cases report The approach is more invasive and requires specialized interventional facilities, limiting its availability. Large randomized trials comparing intra-arterial against intravenous approaches are still needed.
Hyperbaric Oxygen Therapy
Hyperbaric oxygen therapy places the patient in a pressurized chamber breathing pure oxygen. The concept is straightforward: even though the retinal artery is blocked, the choroid, a separate blood supply layer behind the retina, is still functioning. Under hyperbaric conditions, enough oxygen can diffuse from the choroidal circulation through to the inner retina to keep the tissue alive while the blockage either clears on its own or is addressed by another treatment.14PubMed Central. Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives A literature review found that hyperbaric oxygen may reduce macular swelling in CRAO patients, likely by boosting oxygen delivery to the ischemic retina and reducing edema.15International Journal of Social Health. Effectiveness Therapy Oxygen Hyperbaric (HBOT) Against Central Retinal Artery Occlusion (CRAO): Literature Review The practical limitation is that hyperbaric chambers are not available at most hospitals, and the treatment needs to be started quickly to be useful.
CRAO as a Warning of Stroke and Heart Disease
Perhaps the most important development in how doctors think about CRAO is the recognition that it is not just an eye problem. The American Heart Association now classifies CRAO as a form of acute ischemic stroke.16PubMed. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association The retinal artery branches from the same internal carotid artery that supplies the brain, so the same plaque or clot source that sent an embolus to the eye could easily send one to the brain next. A CRAO is, in effect, a warning shot.
Research has shown that over a quarter of patients who show up with CRAO already have evidence of an acute brain stroke, significant carotid artery disease, or other major stroke risk factors at the time of their eye diagnosis.17PubMed. Management of Acute Central Retinal Artery Occlusion, a “Retinal Stroke”: An Institutional Series and Literature Review This is why modern management of CRAO increasingly involves the same urgent workup used for brain strokes: imaging of the carotid arteries, cardiac monitoring, echocardiography to look for heart-based sources of emboli, and blood tests for clotting disorders. Treating the eye alone without investigating the source of the embolus leaves the patient vulnerable to a potentially fatal brain stroke in the near future.
This shift toward a “stroke protocol” mindset is changing where and how CRAO patients are evaluated. Some hospitals have developed specific eye stroke protocols in their emergency departments, using rapid OCT imaging and immediate consultation with both ophthalmology and neurology teams. In one such protocol, patients who arrived within the time window for thrombolysis were able to receive intravenous clot-dissolving drugs, treating the eye and reducing the immediate stroke risk simultaneously.8PubMed. Eye stroke protocol in the emergency department
Complications That Can Follow CRAO
Even after the acute event, the damaged eye remains at risk for further problems. The most serious late complication is neovascular glaucoma, a condition where the oxygen-starved retina sends out chemical distress signals that trigger the growth of abnormal new blood vessels on the iris and in the eye’s drainage angle. These vessels eventually block the outflow of fluid from the eye, causing dangerously high intraocular pressure and additional vision loss on top of the damage already done by the original occlusion.
In one study of 83 eyes with CRAO, about 15% developed some form of new abnormal blood vessel growth. Of those, the vast majority developed iris neovascularization, and over 80% progressed to neovascular glaucoma. The abnormal vessels appeared anywhere from the day of presentation to about four and a half months later, with an average onset around one month.18PubMed Central. Ocular neovascularization in eyes with a central retinal artery occlusion or a branch retinal artery occlusion Another study of 33 patients with nonarteritic CRAO found that about 18% developed ocular neovascularization, with a mean onset of roughly 8.5 weeks. Some of these cases were detected at scheduled follow-ups, but two patients presented through the emergency department with painful eyes at 16 weeks.19PubMed. Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset
The risk of neovascular glaucoma is why eye doctors typically schedule regular follow-up visits for months after a CRAO, even when there seems to be little vision left to save. Catching new vessel growth early allows treatment with laser photocoagulation or anti-VEGF injections before the glaucoma becomes uncontrollable. A case report highlighted that even eyes where a small secondary artery (the cilioretinal artery) was spared and continued providing some blood flow could still develop neovascular glaucoma, meaning no patient should be considered safe from this complication based on the initial exam alone.20PubMed Central. Neovascular Glaucoma Complicating Central Retinal Artery Occlusion Despite Cilioretinal Artery Sparing
How CRAO Affects Daily Life
The functional impact of losing central vision in one eye extends well beyond what you might expect from a condition affecting “only” one side. A study that compared quality-of-life scores between CRAO patients and healthy controls found significantly lower scores across nine of twelve visual function categories. Patients reported greater difficulty with both near and distance activities, reduced peripheral vision, more dependence on others, greater limitations in social situations, and more mental health symptoms related to their vision loss.21Retina. Assessment of Vision-Related Quality of Life in Patients With Central Retinal Artery Occlusion
Losing one eye’s vision disrupts depth perception, narrows the overall visual field, and makes tasks like driving, reading, and navigating stairs harder and more anxiety-provoking. Many patients also deal with the psychological weight of the diagnosis itself: learning that you have had a vascular event linked to stroke risk changes how you think about your health. The combination of sudden disability, cardiovascular anxiety, and an often disappointing response to treatment makes CRAO one of the more psychologically burdensome conditions in ophthalmology.
Emergency Departments and the Changing Standard of Care
Historically, a person who showed up at an emergency room reporting sudden vision loss in one eye might wait hours for an ophthalmology consultation, by which point the retina was well past any realistic treatment window. The reclassification of CRAO as a stroke equivalent is gradually changing that. Hospitals that have implemented eye stroke protocols aim to diagnose the condition within the same aggressive time frames used for brain strokes, using portable OCT and remote image interpretation so that a retinal specialist does not need to be physically present in the emergency department.
The concept behind these protocols is that if a patient with sudden painless vision loss can be diagnosed with CRAO within a few hours, they can receive intravenous thrombolysis on the spot, just as a patient with a brain stroke would. At the same time, the systemic stroke workup begins in parallel: carotid imaging, cardiac monitoring, and evaluation for the embolic source. This dual approach treats the eye and addresses the life-threatening cardiovascular risk simultaneously. The challenge is scaling these protocols beyond the handful of academic centers that have implemented them so far. Most emergency departments do not have OCT devices, and most emergency physicians have not been trained to interpret retinal imaging. Until those gaps close, the majority of CRAO patients will continue to arrive too late for meaningful treatment and leave without a comprehensive vascular evaluation.